Join to View Full Profile
3181 Sw Sam Jackson Park RdOhsuPortland, OR 97239
Phone+1 503-494-8211
Dr. Leonard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2013 - 2016- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2010 - 2013
Northeast Ohio Medical UniversityClass of 2010
Certifications & Licensure
OR State Medical License 2012 - 2025
WA State Medical License 1999 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia Start of enrollment: 2022 Sep 02
- A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia Start of enrollment: 2018 Oct 04
Roles: Principal Investigator
- XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia Start of enrollment: 2022 Feb 02
Roles: Contact
Publications & Presentations
PubMed
- Quality-Adjusted Time Without Symptoms of Disease or Toxicity (Q-TWiST) in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia:...Ajibade Ashaye, Ling Shi, Ibrahim Aldoss, Pau Montesinos, Pankit Vachhani
Cancer Medicine. 2025-04-01 - Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US experts.Nicholas J Short, Ibrahim Aldoss, Daniel J DeAngelo, Marina Konopleva, Jessica Leonard
Blood Advances. 2025-03-25 - 3 citationsOutcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, Chenyu Lin, Simone E Dekker
Journal of Clinical Oncology. 2025-02-10
Abstracts/Posters
- Safety and Efficacy of Venetoclax in Combination with Navitoclax in Adult and Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaJessica Leonard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Simultaneous Kinase Inhibition with Ibrutinib and BCL2 Inhibition with Venetoclax As a Therapeutic Strategy for Acute Lymphoblastic LeukemiaJessica Leonard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
County Increasing Testing Access, Warns of 'Overburdened' HospitalsDecember 9th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
